Loading…
Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction
Saved in:
| Published in: | Bioorganic & medicinal chemistry letters 2006, Vol.16 (4), p.872-875 |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 875 |
| container_issue | 4 |
| container_start_page | 872 |
| container_title | Bioorganic & medicinal chemistry letters |
| container_volume | 16 |
| creator | JONES, Philip ATACK, John R SZETO, Nicola WAFFORD, Keith A MACLEOD, Angus M BRAUN, Matthew P CATO, Brian P CHAMBERS, Mark S O'CONNOR, Desmond COOK, Susan M HOBBS, Sarah C MAXEY, Robert SZEKERES, Helen J |
| description | |
| format | article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_17557062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17557062</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_175570623</originalsourceid><addsrcrecordid>eNqNzs9KAzEQBvBFFKx_3mEuQgs7kHST1h6rqD168CCUUqa72TaaTUqSFuNb-SI-h4_hdql3T8M3349hTrIeFyOBhWDyNOuxyYjh7US8nmcXIbwxxgUTopf9PG_IN1S6d21V1GUAshU0KtLKGR0aCHFXaRXAWSgwKh9xtYvJ4Bj7Elu3SS1zH_TpDBaYzACH2OfHBvkMeT7MBUavOyJbcujcRxrANvnD0s15LrFazDu66Gj7TQ4E9c6WUTtLxiQIyqg27RU8Te-mU_j-kqDtXvmggNbO6hChdh5Kt7a6c1UKfxeusrOaTFDXx3mZ3Tw-vNzPcEuhJFN7sqUOy63XDfm05GMpx2w0LP7rfgHwAHf9</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</title><source>Elsevier</source><creator>JONES, Philip ; ATACK, John R ; SZETO, Nicola ; WAFFORD, Keith A ; MACLEOD, Angus M ; BRAUN, Matthew P ; CATO, Brian P ; CHAMBERS, Mark S ; O'CONNOR, Desmond ; COOK, Susan M ; HOBBS, Sarah C ; MAXEY, Robert ; SZEKERES, Helen J</creator><creatorcontrib>JONES, Philip ; ATACK, John R ; SZETO, Nicola ; WAFFORD, Keith A ; MACLEOD, Angus M ; BRAUN, Matthew P ; CATO, Brian P ; CHAMBERS, Mark S ; O'CONNOR, Desmond ; COOK, Susan M ; HOBBS, Sarah C ; MAXEY, Robert ; SZEKERES, Helen J</creatorcontrib><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Biological and medical sciences ; Contrast media. Radiopharmaceuticals ; Gabaergic and benzodiazepinic system ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments</subject><ispartof>Bioorganic & medicinal chemistry letters, 2006, Vol.16 (4), p.872-875</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17557062$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>JONES, Philip</creatorcontrib><creatorcontrib>ATACK, John R</creatorcontrib><creatorcontrib>SZETO, Nicola</creatorcontrib><creatorcontrib>WAFFORD, Keith A</creatorcontrib><creatorcontrib>MACLEOD, Angus M</creatorcontrib><creatorcontrib>BRAUN, Matthew P</creatorcontrib><creatorcontrib>CATO, Brian P</creatorcontrib><creatorcontrib>CHAMBERS, Mark S</creatorcontrib><creatorcontrib>O'CONNOR, Desmond</creatorcontrib><creatorcontrib>COOK, Susan M</creatorcontrib><creatorcontrib>HOBBS, Sarah C</creatorcontrib><creatorcontrib>MAXEY, Robert</creatorcontrib><creatorcontrib>SZEKERES, Helen J</creatorcontrib><title>Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</title><title>Bioorganic & medicinal chemistry letters</title><subject>Biological and medical sciences</subject><subject>Contrast media. Radiopharmaceuticals</subject><subject>Gabaergic and benzodiazepinic system</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNzs9KAzEQBvBFFKx_3mEuQgs7kHST1h6rqD168CCUUqa72TaaTUqSFuNb-SI-h4_hdql3T8M3349hTrIeFyOBhWDyNOuxyYjh7US8nmcXIbwxxgUTopf9PG_IN1S6d21V1GUAshU0KtLKGR0aCHFXaRXAWSgwKh9xtYvJ4Bj7Elu3SS1zH_TpDBaYzACH2OfHBvkMeT7MBUavOyJbcujcRxrANvnD0s15LrFazDu66Gj7TQ4E9c6WUTtLxiQIyqg27RU8Te-mU_j-kqDtXvmggNbO6hChdh5Kt7a6c1UKfxeusrOaTFDXx3mZ3Tw-vNzPcEuhJFN7sqUOy63XDfm05GMpx2w0LP7rfgHwAHf9</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>JONES, Philip</creator><creator>ATACK, John R</creator><creator>SZETO, Nicola</creator><creator>WAFFORD, Keith A</creator><creator>MACLEOD, Angus M</creator><creator>BRAUN, Matthew P</creator><creator>CATO, Brian P</creator><creator>CHAMBERS, Mark S</creator><creator>O'CONNOR, Desmond</creator><creator>COOK, Susan M</creator><creator>HOBBS, Sarah C</creator><creator>MAXEY, Robert</creator><creator>SZEKERES, Helen J</creator><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>2006</creationdate><title>Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</title><author>JONES, Philip ; ATACK, John R ; SZETO, Nicola ; WAFFORD, Keith A ; MACLEOD, Angus M ; BRAUN, Matthew P ; CATO, Brian P ; CHAMBERS, Mark S ; O'CONNOR, Desmond ; COOK, Susan M ; HOBBS, Sarah C ; MAXEY, Robert ; SZEKERES, Helen J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_175570623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>Contrast media. Radiopharmaceuticals</topic><topic>Gabaergic and benzodiazepinic system</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JONES, Philip</creatorcontrib><creatorcontrib>ATACK, John R</creatorcontrib><creatorcontrib>SZETO, Nicola</creatorcontrib><creatorcontrib>WAFFORD, Keith A</creatorcontrib><creatorcontrib>MACLEOD, Angus M</creatorcontrib><creatorcontrib>BRAUN, Matthew P</creatorcontrib><creatorcontrib>CATO, Brian P</creatorcontrib><creatorcontrib>CHAMBERS, Mark S</creatorcontrib><creatorcontrib>O'CONNOR, Desmond</creatorcontrib><creatorcontrib>COOK, Susan M</creatorcontrib><creatorcontrib>HOBBS, Sarah C</creatorcontrib><creatorcontrib>MAXEY, Robert</creatorcontrib><creatorcontrib>SZEKERES, Helen J</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JONES, Philip</au><au>ATACK, John R</au><au>SZETO, Nicola</au><au>WAFFORD, Keith A</au><au>MACLEOD, Angus M</au><au>BRAUN, Matthew P</au><au>CATO, Brian P</au><au>CHAMBERS, Mark S</au><au>O'CONNOR, Desmond</au><au>COOK, Susan M</au><au>HOBBS, Sarah C</au><au>MAXEY, Robert</au><au>SZEKERES, Helen J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><date>2006</date><risdate>2006</risdate><volume>16</volume><issue>4</issue><spage>872</spage><epage>875</epage><pages>872-875</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><cop>Oxford</cop><pub>Elsevier</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-894X |
| ispartof | Bioorganic & medicinal chemistry letters, 2006, Vol.16 (4), p.872-875 |
| issn | 0960-894X 1464-3405 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_17557062 |
| source | Elsevier |
| subjects | Biological and medical sciences Contrast media. Radiopharmaceuticals Gabaergic and benzodiazepinic system Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments |
| title | Pharmacokinetics and metabolism studies on 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABAA α5 inverse agonist for cognitive dysfunction |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A30%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20and%20metabolism%20studies%20on%203-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)%20pyrazolo%5B1,5-d%5D%5B1,2,4%5Dtriazine,%20a%20functionally%20selective%20GABAA%20%CE%B15%20inverse%20agonist%20for%20cognitive%20dysfunction&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=JONES,%20Philip&rft.date=2006&rft.volume=16&rft.issue=4&rft.spage=872&rft.epage=875&rft.pages=872-875&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E17557062%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_175570623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |